Trial intelligence / Profile preview

Oxygen vs Medical Air for CSA in Prader-Willi Syndrome

NCT03031626Phase 4Completed

Sponsor
SickKids
Start
Sep 2016
Primary completion
Mar 2025
Modality
Inhalation Devices
Countries
1
01

Overview

Phase 4, randomised trial of oxygen in central sleep apnea (CSA) (2 arms), sponsored by SickKids. Primary endpoints: Change in Central Apnea-Hypopnea Index 1, Change in Central Apnea-Hypopnea Index 2 and 1 more. Started Sep 2016; status: completed.

02

Drugs

oxygen
03

Conditions

central sleep apnea (CSA)

Beyond the preview

Go deeper on NCT03031626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03031626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call